DEA extends telemedicine flexibilities for controlled substance prescribing for 2026 - jdsupra.com
DEA extends telemedicine flexibilities for controlled substance prescribing through 2026, allowing continued remote prescribing without in-person exams.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on August 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances prescribed via telemedicine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the source; the extension applies for 2026.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has extended telemedicine flexibilities for controlled substance prescribing for 2026, meaning the temporary rules that allow remote prescribing without an in-person medical evaluation remain in effect for another year.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies that dispense controlled substances prescribed via telemedicine.
What you must do
No immediate action is required, but pharmacies should continue to accept telemedicine prescriptions as currently permitted and monitor for any further DEA guidance or rule changes.
Deadline
Not specified in the source; the extension applies for 2026.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Abortion Exceptionalism: How the New Louisiana Law Classifying Medication Abortion as a “Controlled Substance” Compromises Health Care - National Partnership for Women & Families
- Guidance: Compounding Animal Drugs from Bulk Drug Substances: Compounding under CGMP in Federally-Registered Facilities
- Decision and Order: Atlantic Treatment Center, LLC
- NC pharmacists can now dispense birth control without a prescription. How it works. - Raleigh News & Observer
- Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act